Compare, Analyse GSK Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs MYLAN (US) - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   MYLAN
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
MYLAN
Dec-18
GSK PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3,5953,382-   
Low Rs1,2531,861-   
Sales per share (Unadj.) Rs184.71,556.0-  
Earnings per share (Unadj.) Rs26.342.3-  
Cash flow per share (Unadj.) Rs29.2333.6-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs126.31,683.3-  
Shares outstanding (eoy) m169.40514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x13.11.7 779.2%   
Avg P/E ratio x92.262.0 148.6%  
P/CF ratio (eoy) x83.17.9 1,057.8%  
Price / Book Value ratio x19.21.6 1,232.2%  
Dividend payout %76.10-   
Avg Mkt Cap Rs m410,6261,348,698 30.4%   
No. of employees `0005.035.0 14.2%   
Total wages/salary Rs m5,3720-   
Avg. sales/employee Rs Th6,306.722,872.9 27.6%   
Avg. wages/employee Rs Th1,083.10-   
Avg. net profit/employee Rs Th898.0621.1 144.6%   
INCOME DATA
Net Sales Rs m31,281800,550 3.9%  
Other income Rs m1,0230-   
Total revenues Rs m32,304800,550 4.0%   
Gross profit Rs m6,009207,153 2.9%  
Depreciation Rs m486149,894 0.3%   
Interest Rs m638,504 0.0%   
Profit before tax Rs m6,54018,755 34.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2870-   
Tax Rs m2,373-2,984 -79.5%   
Profit after tax Rs m4,45421,738 20.5%  
Gross profit margin %19.225.9 74.2%  
Effective tax rate %36.3-15.9 -228.1%   
Net profit margin %14.22.7 524.4%  
BALANCE SHEET DATA
Current assets Rs m20,061447,026 4.5%   
Current liabilities Rs m14,543325,932 4.5%   
Net working cap to sales %17.615.1 116.6%  
Current ratio x1.41.4 100.6%  
Inventory Days Days5784 67.9%  
Debtors Days Days1493 15.1%  
Net fixed assets Rs m14,343155,293 9.2%   
Share capital Rs m1,694426 397.4%   
"Free" reserves Rs m19,7040-   
Net worth Rs m21,398866,049 2.5%   
Long term debt Rs m2934,744 0.0%   
Total assets Rs m39,1132,323,079 1.7%  
Interest coverage x1,091.01.5 73,365.0%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.80.3 232.1%   
Return on assets %11.42.6 439.7%  
Return on equity %20.82.5 829.3%  
Return on capital %31.93.2 1,004.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-6,5570-   
CASH FLOW
From Operations Rs m3,994166,354 2.4%  
From Investments Rs m-1,433-85,987 1.7%  
From Financial Activity Rs m-3,584-77,498 4.6%  
Net Cashflow Rs m-1,0231,378 -74.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.04 Rs / USD

Compare GSK PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare GSK PHARMA With: J.B.CHEMICALS  DIVIS LABORATORIES  ALEMBIC LTD  GLENMARK PHARMA  NOVARTIS  



Today's Market

Key Q2FY20 Results, Global Stock Market Drivers, and Top Stocks in Action Today(Pre-Open)

On Monday, Indian share markets traded on a positive note most of the day and ended marginally higher. The BSE Sensex closed higher by 87 points to end the day at 38,214.

Related Views On News

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

GSK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 16.6% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 16.6% YoY). Sales on the other hand came in at Rs 8 bn (up 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Oct 15, 2019 09:25 AM

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA - CADILA HEALTHCARE COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS